| 摘要 |
<p>The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formula I including all solvates, pharmaceutically acceptable salts and stereoisomers, wherein R<SUP>1</SUP> , R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP> and R<SUP>5</SUP> are described herein. '</p> |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY;SUN, CHONGQING;SHER, PHILIP M.;WU, GANG;EWING, WILLIAM R.;HUANG, YANTING;LEE, TAEKYU;MURUGESAN, NATESAN;SULSKY, RICHARD B. |
发明人 |
SUN, CHONGQING;SHER, PHILIP M.;WU, GANG;EWING, WILLIAM R.;HUANG, YANTING;LEE, TAEKYU;MURUGESAN, NATESAN;SULSKY, RICHARD B. |
